In conclusion, we provide insights into the mechanistic links between EMT and lipid metabolism and identify the ZEB2/ACSL4 axis as a novel metastatic metabolic pathway that stimulates both lipogenesis and FAO, resulting in enhanced breast cancer invasion and metastasis. Here, ACSL4 is linked to breast carcinoma.